YOU ARE HERE: LAT HomeCollectionsAspirin


January 30, 2006 | From Times wire reports
Aspirin does not appear to raise the risk that someone who has had one hemorrhagic stroke will have another. Aspirin can cause bleeding, and some doctors had worried it may raise the risk of a bleeding, or hemorrhagic, stroke. But a new study of 207 survivors of intracerebral hemorrhage -- a bleeding stroke -- showed those who were taking aspirin were not more likely to have a second bleeding stroke.
January 18, 2006 | Delthia Ricks, Newsday
Men and women react differently to a host of compounds, and now it appears that there is a sharp gender divide when it comes to aspirin, a team of researchers led by a Long Island heart specialist will report today. The results of the research, published in the Journal of the American Medical Assn., is what is known as a meta-analysis, which means scientists gathered pertinent medical data on aspirin and its protective effects and reanalyzed it. Going into the research, the team, led by Dr.
October 17, 2005 | Timothy Gower, Special to The Times
IN seeking ways to prevent prostate cancer, medical research has frequently turned to the supermarket. Walk around a grocery store and you'll find subjects of intense scientific scrutiny in the produce section (vegetables, especially broccoli), condiment aisle (ketchup and tomato sauce) and vitamin shelf (vitamin E and selenium). In recent years, however, much of the promising research has involved common products found in the pharmacy.
September 5, 2005 | From Times wire reports
Taking aspirin before heart bypass surgery may help patients recover and survive better, researchers have reported. Their study, published in the journal Circulation, should reassure surgeons who have advised patients to avoid taking aspirin in the days before surgery because they feared it could cause bleeding, the researchers said.
August 24, 2005 | From Associated Press
A large study of women weakens hopes that low doses of aspirin could be an easy way to prevent colorectal cancer. Aspirin helps, but its effect is significant only after a decade of use, according to a 20-year study of about 83,000 nurses published Wednesday in the Journal of the American Medical Assn. Low doses of aspirin did not lower cancer risk significantly. High doses of aspirin -- two or more aspirin per day -- reduced colon cancer risk by a third but were linked to dangerous bleeding.
April 11, 2005 | Elizabeth Large, Baltimore Sun
With concerns growing over the health risks associated with painkillers such as Bextra, Vioxx and Celebrex, some Americans may be taking another look at one of the few medicines that have been around since the Victorian era. That would, of course, be aspirin. According to some estimates, a trillion tablets have been taken in its long history. Aspirin is effective, relatively safe and costs as little as a penny a tablet. So what's not to like?
March 31, 2005 | Thomas H. Maugh II, Times Staff Writer
Aspirin is as good as the anticoagulant drug warfarin at preventing strokes caused by partial blockage of arteries in the brain, and it is much safer, according to the first clinical trial comparing the two treatments. The trial was halted prematurely, in fact, because of hemorrhaging and deaths associated with using warfarin, researchers report today in the New England Journal of Medicine.
March 14, 2005 | Thomas H. Maugh II, Times Staff Writer
In what scientists said was the first new treatment in a decade for heart attacks, researchers reported last week that the drug clopidogrel, when used in combination with other standard treatments, could prevent repeat heart attacks and reduce death rates by as much as 36%. Taken together, the findings of three studies presented at the American College of Cardiology meeting last week in Orlando, Fla.
March 8, 2005 | Thomas H. Maugh II, Times Staff Writer
A small dose of aspirin taken regularly reduces the risk of heart attack and stroke by about a third in women older than 65 but does not significantly cut the risk in younger women, according to a 10-year study that examined the drug's effects in women for the first time. For women older than 65, the decision to prescribe aspirin should be made on exactly the same basis as it is in men, the study found. The findings elevate aspirin's role in preventing heart disease in older women.
January 1, 2005
Re "Big Pharma's Dirty Little Secret," Commentary, Dec. 26: Rather than worrying about how to pay for all these expensive new drugs from big pharma, it is time society asked how much of this is necessary or even useful. There are a few real "wonder drugs" that save lives and maintain health, but most new brand-name drugs are very expensive replacements for perfectly adequate generic (off-patent) drugs that could be used just as well (and sometimes better) to treat self-limited or patient-induced conditions.
Los Angeles Times Articles